Cargando…
The Treatment of Arterial Hypertension
Arterial hypertension is the leading cause of death worldwide and is one of the most important public health problems. Arterial hypertension is a major cardiovascular risk factor with an increasing incidence. In this paper we set out to analyze a group of 3050 patients hospitalized between January 2...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical University Publishing House Craiova
201
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014987/ https://www.ncbi.nlm.nih.gov/pubmed/32110437 http://dx.doi.org/10.12865/CHSJ.45.04.03 |
_version_ | 1783496744389050368 |
---|---|
author | BRAȘOVEANU, AM CRUCE, R MOGOANTĂ, L CÂRLIG, V |
author_facet | BRAȘOVEANU, AM CRUCE, R MOGOANTĂ, L CÂRLIG, V |
author_sort | BRAȘOVEANU, AM |
collection | PubMed |
description | Arterial hypertension is the leading cause of death worldwide and is one of the most important public health problems. Arterial hypertension is a major cardiovascular risk factor with an increasing incidence. In this paper we set out to analyze a group of 3050 patients hospitalized between January 2013 and December 2017 in terms of drug therapy. We found that the majority of patients received drug treatment with a converting-enzyme inhibitor as a monotherapy, and the most common drug association was the association between conversion enzyme inhibitor and calcium channel blocker. |
format | Online Article Text |
id | pubmed-7014987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 201 |
publisher | Medical University Publishing House Craiova |
record_format | MEDLINE/PubMed |
spelling | pubmed-70149872020-02-27 The Treatment of Arterial Hypertension BRAȘOVEANU, AM CRUCE, R MOGOANTĂ, L CÂRLIG, V Curr Health Sci J Original Paper Arterial hypertension is the leading cause of death worldwide and is one of the most important public health problems. Arterial hypertension is a major cardiovascular risk factor with an increasing incidence. In this paper we set out to analyze a group of 3050 patients hospitalized between January 2013 and December 2017 in terms of drug therapy. We found that the majority of patients received drug treatment with a converting-enzyme inhibitor as a monotherapy, and the most common drug association was the association between conversion enzyme inhibitor and calcium channel blocker. Medical University Publishing House Craiova 2019 2019-12-30 /pmc/articles/PMC7014987/ /pubmed/32110437 http://dx.doi.org/10.12865/CHSJ.45.04.03 Text en Copyright © 2019, Medical University Publishing House Craiova http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited. |
spellingShingle | Original Paper BRAȘOVEANU, AM CRUCE, R MOGOANTĂ, L CÂRLIG, V The Treatment of Arterial Hypertension |
title | The Treatment of Arterial Hypertension |
title_full | The Treatment of Arterial Hypertension |
title_fullStr | The Treatment of Arterial Hypertension |
title_full_unstemmed | The Treatment of Arterial Hypertension |
title_short | The Treatment of Arterial Hypertension |
title_sort | treatment of arterial hypertension |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014987/ https://www.ncbi.nlm.nih.gov/pubmed/32110437 http://dx.doi.org/10.12865/CHSJ.45.04.03 |
work_keys_str_mv | AT brasoveanuam thetreatmentofarterialhypertension AT crucer thetreatmentofarterialhypertension AT mogoantal thetreatmentofarterialhypertension AT carligv thetreatmentofarterialhypertension AT brasoveanuam treatmentofarterialhypertension AT crucer treatmentofarterialhypertension AT mogoantal treatmentofarterialhypertension AT carligv treatmentofarterialhypertension |